✦ LIBER ✦

Safety, tolerability and efficacy of indacaterol, a novel once-daily β2-agonist, in patients with COPD: A 28-day randomised, placebo controlled clinical trial

✍ Scribed by Jutta Beier; Pascal Chanez; Jean-Benoit Martinot; A.J.M. Schreurs; Ružena Tkáčová; Weibin Bao; Damon Jack; Mark Higgins

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tolerability of indacaterol, a novel onc

✍ Yang, William H.; Martinot, Jean Benoit; Pohunek, Petr; Beier, Jutta; Magula, Da 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 268 KB

Indacaterol, A Novel Once-Daily β2-Agoni

✍ Kanniess, F.; Cameron, R.; Owen, R.; Higgins, M. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 225 KB

28-Day safety and tolerability of umecli

✍ Gregory Feldman; Robert R. Walker; Jean Brooks; Rashmi Mehta; Glenn Crater 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 411 KB

Single and Multiple Doses of Indacaterol

✍ Brookman, L.; Knight, H.; Wood, J.; Perry, S.; Tarral, A.; Elharrar, B.; Pascoe, 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 212 KB

Efficacy and safety of linagliptin 2.5 m

✍ Ross, Stuart A.; Rafeiro, Elizabeth; Meinicke, Thomas; Toorawa, Robert; Weber-Bo 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 254 KB

Efficacy and safety of fluticasone furoa

✍ Lötvall, Jan; Bleecker, Eugene R.; Busse, William W.; O'Byrne, Paul M.; Woodcock 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 621 KB